Service area · GDP logistics
From goods receipt to patient handover, every temperature-relevant medicine needs a product-, pack- and route-specific quality concept. Blanket temperature promises never replace a qualified supply chain.
Discuss your project →GDP · temperature control · last mile
From goods receipt to patient handover, every temperature-relevant medicine needs a product-, pack- and route-specific quality concept. Blanket temperature promises never replace a qualified supply chain.
tiger.PHARMA designs and reviews temperature control for storage, B2B transport and B2C delivery: with defensible product data, packaging and route qualification, controlled carrier performance and documented decisions for deviations and returns.
The starting point is not a generic cold label but the approved product information and stability evidence that is reliable for the particular supply chain.
Packaging, transit time and route are assessed as one configuration, including season, handover point and realistic delay scenarios.
The last mile is not determined by shipping method alone. Medicine, patient group, delivery location, handover and carrier performance form one risk profile.
Measurement should be meaningful, not decorative. Sensors, indicators and data loggers are selected according to the risk assessment and controlled by quality processes.
A temperature deviation or returned parcel is a quality case: secure first, assess second, then let the responsible role make a traceable decision.
Warehouse and wholesale processes and direct patient delivery need different controls, but can be managed through one shared quality picture.
FAQ
No. The approved product information, defensible stability data and the qualified packaging and route configuration are decisive. A general temperature assumption does not replace a product-specific assessment.
By combining the product profile, packaging, route, season, delivery model, carrier performance and documented delay scenarios. The configuration is assessed before routine use and monitored according to risk.
The parcel or return is secured or blocked. Measurements, time, route, packaging and product requirements are assessed, then the responsible quality role documents release, rejection or further action.
No. MKT can only be used as supportive evidence when product-specific stability data, a qualified measurement concept and a written quality decision permit it.